ENTITY
Livzon Pharmaceutical Group

Livzon Pharmaceutical Group (1513 HK)

108
Analysis
Health Care • China
Livzon Pharmaceutical Group is a comprehensive pharmaceutical company engaged in the research, development, production, and sales of various pharmaceutical products. Its portfolio includes chemical drugs, biological drugs, traditional Chinese medicine, and in vitro diagnostic reagents, covering therapeutic areas such as digestion, cardiovascular, reproductive endocrinology, and mental/nervous systems. The company was founded in January 1985 and is headquartered in Zhuhai City, Guangdong Province, China.
more
•19 Feb 2021 15:34

SciClone Pharmaceuticals IPO: Valuation Insights

SciClone has launched its IPO to raise net proceeds of $252m, at the mid-point of the price range. We recommend a pass as our concerns on the...

Logo
1.1k Views
Share
•18 Feb 2021 09:54

Innovent Biologics (1801 HK) - Have the Genes to Become a Big Pharma

This article mainly analyzed Innovent in terms of its current listed products (Sintilimab, Bevacizumab, Adalimumab and Rituximab), its pipeline,...

Logo
639 Views
Share
•28 Nov 2020 18:37

Quiddity Weekly H/​​A: Share Spread Monitor as of 27 Nov 2020

The weekly H/A Share Monitor and Trade Recommendations. Spreads narrower on the week. Last week's 39 trade recommendations gained 0.67% on average....

Logo
359 Views
Share
•23 Nov 2020 14:04

Quiddity Weekly H/A: Share Spread Monitor as of 20 Nov 2020

The H-Share/A-Share monitor is published every weekend for the data ending the last trading day of the previous week. It includes all H-Share/A...

Logo
387 Views
Share
•14 Nov 2020 17:50

Quiddity Weekly H/A: Share Spread Monitor 13 Nov 2020

The Quiddity H/A-Share Spread Monitor for the week ending 13 November 2020. Momentum on a spread basis continues, but momentum on a sector basis...

Logo
295 Views
Share
x